Alteration of inhibitory and activating NK cell receptor expression on NK cells in HIV-infected Chinese

Cellular Immunology

Volumn 271, Issue 2, 2011, Pages 219-226

  Jiang, Yongjun ^a   He, Lei ^a   Chen, Huan ^a   Bice, Tristan ^a   Zhang, Zining ^a   Liu, Jing ^a   Ding, Haibo ^a   Han, Xiaoxu ^a   Shang, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

HIV; NK cells; NK receptors; NK subsets

Indexed keywords

ANTIRETROVIRUS AGENT; CD56 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL FUNCTION; CELLULAR IMMUNITY; CHINESE; CONTROLLED STUDY; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PHENOTYPIC VARIATION; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIGENS, CD56; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, KIR3DL1; RECEPTORS, NATURAL KILLER CELL; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80054018068     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.06.026     Document Type: Article

References (34)

1. Alter G., Altfeld M. NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J. Intern. Med. 2009, 265:29-42.
2. Caligiuri M.A. Human natural killer cells. Blood 2008, 112:461-469.
3. Bryceson Y.T., Ljunggren H.G., Long E.O. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009, 114:2657-2666.
4. Joncker N.T., Fernandez N.C., Treiner E., Vivier E., Raulet D.H. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J. Immunol. 2009, 182:4572-4580.
5. Al-Hubeshy Z.B., Coleman A., Nelson M., Goodier M.R. A rapid method for assessment of natural killer cell function after multiple receptor crosslinking. J. Immunol. Methods 2011, 366:52-59.
6. Pace E., Di Sano C., Ferraro M., Tipa A., Olivieri D., Spatafora M., Santagata R., Bellia V., Gjomarkaj M. Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions. Eur. J. Cancer 2011, 47:296-304.
7. Thananchai H., Gillespie G., Martin M.P., Bashirova A., Yawata N., Yawata M., Easterbrook P., McVicar D.W., Maenaka K., Parham P., Carrington M., Dong T., Rowland-Jones S. Cutting Edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 2007, 178:33-37.
8. Obeidy P., Sharland A.F. NKG2D and its ligands. Int. J. Biochem. Cell Biol. 2009, 41:2364-2367.
9. Bryceson Y.T., March M.E., Ljunggren H.G., Long E.O. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 2006, 214:73-91.
10. Long E.O. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 2008, 224:70-84.
11. Romagnani C., Juelke K., Falco M., Morandi B., D'Agostino A., Costa R., Ratto G., Forte G., Carrega P., Lui G., Conte R., Strowig T., Moretta A., Munz C., Thiel A., Moretta L., Ferlazzo G. CD56brightCD16-killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 2007, 178:4947-4955.
12. Bjorkstrom N.K., Ljunggren H.G., Sandberg J.K. CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol. 2010, 31:401-406.
13. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001, 97:3146-3151.
14. Hu P.F., Hultin L.E., Hultin P., Hausner M.A., Hirji K., Jewett A., Bonavida B., Detels R., Giorgi J.V. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 10:331-340.
15. Eller M.A., Eller L.A., Ouma B.J., Thelian D., Gonzalez V.D., Guwatudde D., McCutchan F.E., Marovich M.A., Michael N.L., de Souza M.S., Wabwire-Mangen F., Robb M.L., Currier J.R., Sandberg J.K. Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection. J. Acquir. Immune Defic. Syndr. 2009, 51:380-389.
16. Zhang R., Xu J., Hong K., Yuan L., Peng H., Tang H., Ma P., Zhang Y., Xing H., Ruan Y., Shao Y. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status. AIDS 2007, 21(Suppl. 8):S9-S17.
17. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., Marcenaro E., Bottino C., Moretta L., Moretta A., Fauci A.S. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. USA 2003, 100:15011-15016.
18. Mela C.M., Burton C.T., Imami N., Nelson M., Steel A., Gazzard B.G., Gotch F.M., Goodier M.R. Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy. AIDS 2005, 19:1761-1769.
19. Kottilil S., Shin K., Planta M., McLaughlin M., Hallahan C.W., Ghany M., Chun T.W., Sneller M.C., Fauci A.S. Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. J. Infect. Dis. 2004, 189:1193-1198.
20. Feng Y.M., Zhang R.J., Zhu H., Peng H., Zhou X.P., Hong K.X., Liu J.L., Chen J.P., Shao Y.M. Comparison of the quantities and subset distributions of natural killer cells among different races. Chin. Med. J. (Engl.) 2010, 123:3272-3276.
21. Middleton D., Meenagh A., Moscoso J., Arnaiz-Villena A. Killer immunoglobulin receptor gene and allele frequencies in Caucasoid, Oriental and Black populations from different continents. Tissue Antigens 2008, 71:105-113.
22. Biassoni R., Fogli M., Cantoni C., Costa P., Conte R., Koopman G., Cafaro A., Ensoli B., Moretta A., Moretta L., De Maria A. Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection. J. Immunol. 2005, 174:5695-5705.
23. Fu G.F., Hao S., Zhao J.L., Xu X.Q., Guo H.X., Hu H.Y., Yang H.T., Li L., Xu J.S., Qiu T., Huan X.P., Hou Y.Y. Changes in NK cell counts and receptor expressions and emergence of CD3(dim)/CD56+ cells in HIV-1 infected patients in China. Viral Immunol. 2009, 22:105-116.
24. Doubrovina E.S., Doubrovin M.M., Vider E., Sisson R.B., O'Reilly R.J., Dupont B., Vyas Y.M. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J. Immunol. 2003, 171:6891-6899.
25. Coudert J.D., Zimmer J., Tomasello E., Cebecauer M., Colonna M., Vivier E., Held W. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 2005, 106:1711-1717.
26. Nolting A., Dugast A.S., Rihn S., Luteijn R., Carrington M.F., Kane K., Jost S., Toth I., Nagami E., Faetkenheuer G., Hartmann P., Altfeld M., Alter G. MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction. Virology 2010, 406:12-20.
27. Bonaparte M.I., Barker E. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 2004, 104:2087-2094.
28. Nattermann J., Feldmann G., Ahlenstiel G., Langhans B., Sauerbruch T., Spengler U. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 2006, 55:869-877.
29. O'Connor G.M., Holmes A., Mulcahy F., Gardiner C.M. Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function. Clin. Immunol. 2007, 124:277-283.
30. Parato K.G., Kumar A., Badley A.D., Sanchez-Dardon J.L., Chambers K.A., Young C.D., Lim W.T., Kravcik S., Cameron D.W., Angel J.B. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS 2002, 16:1251-1256.
31. Golden-Mason L., Madrigal-Estebas L., McGrath E., Conroy M.J., Ryan E.J., Hegarty J.E., O'Farrelly C., Doherty D.G. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 2008, 57:1121-1128.
32. Meier U.C., Owen R.E., Taylor E., Worth A., Naoumov N., Willberg C., Tang K., Newton P., Pellegrino P., Williams I., Klenerman P., Borrow P. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J. Virol. 2005, 79:12365-12374.
33. Kottilil S., Jackson J.O., Reitano K.N., O'Shea M.A., Roby G., Lloyd M., Yang J., Hallahan C.W., Rehm C.A., Arthos J., Lempicki R., Fauci A.S. Innate immunity in HIV infection: enhanced susceptibility to CD95-mediated natural killer cell death and turnover induced by HIV viremia. J. Acquir. Immune Defic. Syndr. 2007, 46:151-159.
34. Vitale M., Della Chiesa M., Carlomagno S., Romagnani C., Thiel A., Moretta L., Moretta A. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur. J. Immunol. 2004, 34:1715-1722.